Advisor Group Holdings, Inc. Bria Cell Therapeutics Corp. Transaction History

Advisor Group Holdings, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	BUY	$5.91 - $10.14 $118 - $202	20 Added 166.67%	32 $0
Q2 2021 Aug 02, 2021	SELL	$2.89 - $6.57 $17,340 - $39,420	-6,000 Reduced 99.8%	12 $0
Q1 2021 May 13, 2021	BUY	$3.15 - $6.17 $18,937 - $37,094	6,012 New	6,012 $23,000

Ticker BCTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,518,000
Market Cap $11.8M
Description
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.